CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer
- DOI
- 10.1080/17435889.2026.2732014
- Published
- 2026-09-10
- Container
- Nanomedicine
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/17435889.2026.2732014,
title = {CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer},
author = {Swarupananda Mukherjee and Dipanjan Karati and Sinjini Sarkar and Dipanjana Ash and Shayeri Chatterjee Ganguly and Ayon Dutta and Rajesh Kesarla},
year = {2026},
journal = {Nanomedicine},
doi = {10.1080/17435889.2026.2732014},
url = {https://doi.org/10.1080/17435889.2026.2732014}
}RIS
TY - JOUR TI - CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer AU - Swarupananda Mukherjee AU - Dipanjan Karati AU - Sinjini Sarkar AU - Dipanjana Ash AU - Shayeri Chatterjee Ganguly AU - Ayon Dutta AU - Rajesh Kesarla PY - 2026 JO - Nanomedicine DO - 10.1080/17435889.2026.2732014 UR - https://doi.org/10.1080/17435889.2026.2732014 ER -
APA
Mukherjee, S., Karati, D., Sarkar, S., Ash, D., Ganguly, S. C., Dutta, A., & Kesarla, R. (2026). CRISPR-Cas9‑based lipid nanocarriers for advanced therapy of urinary bladder cancer. Nanomedicine. https://doi.org/10.1080/17435889.2026.2732014
Source records
- crossref · retrieved 2026-09-25T15:01:38.567Z